Application 076233
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PACLITAXEL | PACLITAXEL | INJECTABLE;INJECTION | 6MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076233-001 | PACLITAXEL | PACLITAXEL | 6MG/ML | INJECTABLE / INJECTION | 2002-08-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076233-001 | PACLITAXEL | 6MG/ML | INJECTABLE / INJECTION | 2002-08-01 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Paclitaxel | PACLITAXEL | Teva Parenteral Medicines, Inc. | fbd32bd2-9685-41cb-bee2-730a45526b65 | 2026-07-11 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| Paclitaxel | PACLITAXEL | Teva Parenteral Medicines, Inc. | e4be6cbf-72b9-4f7f-9b1b-459b2d35961a | 2026-07-03 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| Paclitaxel | PACLITAXEL | Hospira, Inc. | ea28753a-8631-460a-bfdc-b101eb8ac84a | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| Paclitaxel | PACLITAXEL | BluePoint Laboratories | 59906bd2-8337-4cd8-9288-65b90eac2a7a | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| PACLITAXEL | PACLITAXEL | Mylan Institutional LLC | a1a06de1-d9a4-460a-b87d-5e40305b065c | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | PACLITAXEL PACLITAXEL |
| Paclitaxel | PACLITAXEL | Bryant Ranch Prepack | 30384708-1fcd-4a75-94d7-9d5d617a37b6 | 2026-05-06 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| Paclitaxel | PACLITAXEL (AIBUMIN-BOUND) | Ningbo Shuangcheng Pharmaceutical Co., Ltd | 4df3fda6-0b29-420e-ab91-81441ce914ed | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | Paclitaxel |
| Paclitaxel | PACLITAXEL | Natco Pharma USA LLC | a1eb16b4-285b-4e81-9c4e-1244d4a52af8 | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| PACLITAXEL PACLITAXEL | PACLITAXEL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | b4c5d08a-e0f5-4af1-97d6-213705adedf1 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | PACLITAXEL |
| Paclitaxel protein-bound particles for injectable suspension (albumin-bound) | PACLITAXEL | NorthStar Rx LLC | 1e9d5093-fbfc-470a-8520-811c46a8870c | 2025-09-17 | Boxed warning, Warnings, Adverse reactions | PACLITAXEL |
| Paclitaxel protein-bound particles for injectable suspension (albumin-bound) | PACLITAXEL | BluePoint Laboratories | 36d4a2ed-4b34-4b06-e063-6394a90acc86 | 2025-08-13 | Boxed warning, Warnings, Adverse reactions | PACLITAXEL |
| Paclitaxel | PACLITAXEL | BluePoint Laboratories | 9e7bc2c2-a369-4c6f-9dd9-ee98ddaae833 | 2025-07-07 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| Paclitaxel | PACLITAXEL | Sandoz Inc | 15ca4829-8fee-45f9-b4bc-b31c15732cd6 | 2025-06-11 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| Paclitaxel protein-bound particles for injectable suspension (albumin-bound) | PACLITAXEL | Meitheal Pharmaceuticals Inc. | 31e893aa-8d9e-4576-8614-eb2fe772bde4 | 2025-05-22 | Boxed warning, Warnings, Adverse reactions | PACLITAXEL |
| Paclitaxel | PACLITAXEL | Fresenius Kabi USA, LLC | a6c24189-293f-42ca-b969-75870bb55af0 | 2024-09-19 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| Paclitaxel | PACLITAXEL | Alembic Pharmaceuticals Inc. | 0c12c77c-5fd4-48dc-a318-e96892233992 | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| Paclitaxel | PACLITAXEL | Sagent Pharmaceuticals | 5721b9bf-c3c1-4b73-b96c-5fbe3147b6a5 | 2024-01-20 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| Paclitaxel | PACLITAXEL | Teva Pharmaceuticals, Inc. | 15dd51ed-29e8-468b-b6d1-21b1f84d6f2e | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
| PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND | PACLITAXEL | American Regent, Inc. | f06d1bb3-83f1-4d84-8004-4c6681ad8a5a | 2023-05-01 | Boxed warning, Warnings, Adverse reactions | PACLITAXEL |
| Paclitaxel | PACLITAXEL | Alembic Pharmaceuticals Limited | 6d04b514-c85c-4db1-919e-21dd98172791 | 2023-01-31 | Boxed warning, Warnings, Adverse reactions | Paclitaxel PACLITAXEL |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 43065 | ORIG | 2005-07-22 |